Literature DB >> 28524065

MicroRNA in skin diseases.

Tatiana G Ruksha1, Anna V Komina1, Nadezhda V Palkina1.   

Abstract

MicroRNAs are essential regulators of various cellular processes such as cell growth, differentiation, apoptosis, and the immune response, acting as factors for translational repression and/or degradation of target messenger RNA. Currently, microRNAs are considered as promising biomarkers and therapeutic targets for different pathological conditions. Skin may serve as a convenient model for microRNA modulation studies due to the comparatively easy access to targets cells. Cutaneous diseases are characterized by multiple intercellular communication pathways, triggered by diverse stimuli and mediated by heterogenous regulators, including microRNAs. The goal of this article is to summarize the state of research in dermatology concerning the action of microRNAs as epigenetic modulators.

Entities:  

Keywords:  atopic dermatitis; lichen planus; microRNA; psoriasis; skin disease; vitiligo

Mesh:

Substances:

Year:  2017        PMID: 28524065     DOI: 10.1684/ejd.2017.3024

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  9 in total

Review 1.  The role of microRNAs in diseases and related signaling pathways.

Authors:  Atena Vaghf; Behzad Khansarinejad; Ehsanollah Ghaznavi-Rad; Mahdieh Mondanizadeh
Journal:  Mol Biol Rep       Date:  2021-10-31       Impact factor: 2.742

Review 2.  MicroRNA in localized scleroderma: a review of literature.

Authors:  Katarzyna Wolska-Gawron; Joanna Bartosińska; Dorota Krasowska
Journal:  Arch Dermatol Res       Date:  2019-10-21       Impact factor: 3.017

Review 3.  Understanding psoriasis: Role of miRNAs.

Authors:  Teodora Larisa Timis; Remus Ioan Orasan
Journal:  Biomed Rep       Date:  2018-09-11

Review 4.  Melanoma and Vitiligo: In Good Company.

Authors:  Cristina Maria Failla; Maria Luigia Carbone; Cristina Fortes; Gianluca Pagnanelli; Stefania D'Atri
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

5.  Human bone marrow mesenchymal stem cell-derived extracellular vesicles inhibit shoulder stiffness via let-7a/Tgfbr1 axis.

Authors:  Zhiwen Luo; Yaying Sun; Beijie Qi; Jinrong Lin; Yisheng Chen; Yuzhen Xu; Jiwu Chen
Journal:  Bioact Mater       Date:  2022-01-23

6.  Diagnosis value of miR-181, miR-652, and CA72-4 for gastric cancer.

Authors:  Wenyan Tian; Xueqin Pang; Fujuan Luan
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

7.  MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.

Authors:  Li Chai; Xiao-Jing Kang; Zhen-Zhu Sun; Ming-Feng Zeng; Shi-Rong Yu; Yuan Ding; Jun-Qin Liang; Ting-Ting Li; Juan Zhao
Journal:  Cancer Manag Res       Date:  2018-05-03       Impact factor: 3.989

8.  Identification of Altered miRNAs in Cerumen of Dogs Affected by Otitis Externa.

Authors:  Cristina Lecchi; Valentina Zamarian; Giorgia Borriello; Giorgio Galiero; Guido Grilli; Mario Caniatti; Elisa Silvia D'Urso; Paola Roccabianca; Roberta Perego; Michela Minero; Sara Legnani; Raffaele Calogero; Maddalena Arigoni; Fabrizio Ceciliani
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

9.  Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers.

Authors:  Katarzyna Wolska-Gawron; Joanna Bartosińska; Marta Rusek; Małgorzata Kowal; Dorota Raczkiewicz; Dorota Krasowska
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.